文献速递产科母胎医学

在全民筛查国家中主要心脏缺陷的产前检出与结局

Prenatal detection and outcome of major heart defects in a country with universal screening.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-10-21

丹麦2018年1月至2022年12月全国队列研究纳入602例主要胎儿先天性心脏病(mCHD),产前检出率为82.6%(497/602),终止妊娠率为43.4%(261/602),活产发生率为0.11%(1.1/1000活产),活产儿死亡率为9.8%(32/326)。

要点

  • mCHD产前总检出率为82.6%(497/602),单心室心脏检出率最高(99.4%,159/160),完全性肺静脉异位引流最低(7.7%,1/13)。
  • 产前检出病例中52.5%(261/497)选择终止妊娠,总终止妊娠率为43.4%(261/602)。
  • 活产儿中92.0%(300/326)接受手术,多在出生后第一个月内;活产儿死亡率为9.8%(32/326),其中50.0%为新生儿期未手术死亡。

核心结论

  • 丹麦全国筛查项目下mCHD产前检出率提高、活产发生率下降,提示国家筛查计划和集中化管理的有效性;绝大多数患者接受手术治疗,死亡率低。
  • 活产mCHD发生率下降应持续监测并进一步探索潜在原因。

研究设计与样本

  • 丹麦2018年1月至2022年12月开展的5年全国性队列研究。
  • 纳入疑似和/或确诊mCHD的妊娠及确诊mCHD的儿童,排除未筛查者、假阳性病例及分娩前移居者。
  • 共检索645例妊娠和儿童数据,最终分析纳入602例。

主要发现

  • mCHD产前检出率为82.6%(497/602);单心室心脏检出率99.4%(159/160),完全性肺静脉异位引流检出率7.7%(1/13)。
  • 终止妊娠发生于43.4%(261/602)病例,产前检出病例中52.5%(261/497)选择终止妊娠。
  • mCHD活产发生率为0.11%(1.1/1000活产),分娩中位孕周为39+2周。
  • 活产儿中92.0%(300/326)接受手术,主要在出生后第一个月内。
  • 产后随访8个月至5年,死亡率为9.8%(32/326),其中50.0%发生于新生儿期且未手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the Danish prenatal screening program for major fetal congenital heart defects (mCHD), focusing on incidence, detection rates (DRs), pregnancy outcomes and postnatal mortality. METHODS: This was a 5-year nationwide cohort study conducted from January 2018 to December 2022 in Denmark. We included pregnancies suspected of and/or with a confirmed mCHD and children with a confirmed mCHD, and excluded those who were not screened, false-positive cases and those who emigrated before delivery. The main outcome was the prenatal DR of mCHD. Secondary outcomes were rate of termination of pregnancy, liveborn incidence of mCHD, gestational age at delivery, neonatal surgery rate and postnatal mortality. RESULTS: Data from a total of 645 pregnancies and children with mCHD were retrieved from local databases and 602 were included in the final analysis. The prenatal DR of mCHD was 82.6% (497/602), with one of the highest DRs observed for univentricular heart (99.4% (159/160)) and the lowest DR for total anomalous pulmonary venous return (7.7% (1/13)). Termination of pregnancy occurred in 43.4% (261/602) of cases, with 52.5% (261/497) of prenatally detected cases opting for termination. The liveborn incidence of mCHD was 0.11% (1.1 per 1000 births), and the median gestational age at delivery was 39 + 2 weeks. Surgery was performed in 92.0% (300/326) of liveborn children, primarily within the first month after birth. The postnatal follow-up time was between 8 months and 5 years, with a mortality rate of 9.8% (32/326), of which 50.0% occurred neonatally without surgery. CONCLUSIONS: This study highlights increased prenatal DRs and a declining liveborn incidence of mCHD in Denmark, underscoring the efficacy of the national screening program and centralized care. Furthermore, the vast majority of patients were treated surgically, and the mortality rate was low. The declining liveborn incidence of mCHD should be monitored and potential causes explored further. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vedel C, Steensberg J, Petersen OB, et al. Prenatal detection and outcome of major heart defects in a country with universal screening. Ultrasound Obstet Gynecol. 2025. PMID: 41118659. doi:10.1002/uog.70107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。